| Literature DB >> 28638804 |
Sofiya N Micheva-Viteva1, Yulin Shou1, Kumkum Ganguly1, Terry H Wu2, Elizabeth Hong-Geller1.
Abstract
Pathogenic Burkholderia rely on host factors for efficient intracellular replication and are highly refractory to antibiotic treatment. To identify host genes that are required by Burkholderia spp. during infection, we performed a RNA interference (RNAi) screen of the human kinome and identified 35 host kinases that facilitated Burkholderia thailandensis intracellular survival in human monocytic THP-1 cells. We validated a selection of host kinases using imaging flow cytometry to assess efficiency of B. thailandensis survival in the host upon siRNA-mediated knockdown. We focused on the role of the novel protein kinase C isoform, PKC-η, in Burkholderia infection and characterized PKC-η/MARCKS signaling as a key event that promotes the survival of unopsonized B. thailandensis CDC2721121 within host cells. While infection of lung epithelial cells with unopsonized Gram-negative bacteria stimulated phosphorylation of Ser175/160 in the MARCKS effector domain, siRNA-mediated knockdown of PKC-η expression reduced the levels of phosphorylated MARCKS by >3-fold in response to infection with Bt CDC2721121. We compared the effect of the conventional PKC-α and novel PKC-η isoforms on the growth of B. thailandensis CDC2721121 within monocytic THP-1 cells and found that ≥75% knock-down of PRKCH transcript levels reduced intracellular bacterial load 100% more efficiently when compared to growth in cells siRNA-depleted of the classical PKC-α, suggesting that the PKC-η isoform can specifically mediate Burkholderia intracellular survival. Based on imaging studies of intracellular B. thailandensis, we found that PKC-η function stimulates phagocytic pathways that promote B. thailandensis escape into the cytoplasm leading to activation of autophagosome flux. Identification of host kinases that are targeted by Burkholderia during infection provides valuable molecular insights in understanding Burkholderia pathogenesis, and ultimately, in designing effective host-targeted therapies against infectious disease caused by intracellular pathogens.Entities:
Keywords: Burkholderia; RNA interference; autophagy; infection; intracellular bacteria; protein kinase C
Mesh:
Substances:
Year: 2017 PMID: 28638804 PMCID: PMC5461351 DOI: 10.3389/fcimb.2017.00231
Source DB: PubMed Journal: Front Cell Infect Microbiol ISSN: 2235-2988 Impact factor: 5.293
Host genes required for intracellular B. thailandensis proliferation.
| ABL1 | Protein tyrosine kinase | Cell division differentiation, adhesion, and stress | |
| AKT1/PKB | Serine/threonine-protein kinase | Cell survival, growth, proliferation, motility | |
| AKT2/PKBB | Serine/threonine-protein kinase | Cell survival, insulin signaling, motility | |
| AURKA | Cell cycle-regulated serine/threonine kinase | Organizing microtubules during cell division | |
| AURKC | Serine/threonine/tyrosine kinase | Mitosis and meiosis | |
| CALM1 | Calcium binding phosphorylase kinase | Centrosome cycle, cytokinesis, cell signaling | |
| CAMK1G | Ca++/calmodulin-dependent kinase | Ca++-triggered signaling cascade | |
| CAMK2A | Serine/threonine kinase | Gene transcription, cell survival, apoptosis, cytoskeleton | |
| CAMK2B | Serine/threonine kinase | Same as CAMK2A | |
| CAMKK2 | Ca++/calmodulin-dependent serine/threonine kinase | Gene transcription, cell survival, cytoskeleton reorganization | |
| EPHA3 | Receptor protein-tyrosine kinase | Cell signaling, development, migration | |
| EPHB2 | Receptor protein-tyrosine kinase | Cell signaling, development, migration, and adhesion | |
| ERBB3/ cErbB3 | Receptor tyrosine kinase | Gene expression, cytoskeletal rearrangement, cell survival | |
| HK1 | Produce glucose-6-phosphate | Glycolysis, energy generation | |
| HK2 | Produce glucose-6-phosphate | Glycolysis, energy generation | |
| HK3 | Produce glucose-6-phosphate | Glycolysis, energy generation | |
| INSRR | Transmembrane receptor protein tyrosine kinase | Cell signaling, apoptosis, pH sensor | |
| ITPKA/IP3KA | Phosphorylation of inositol 1,4,5-trisphosphate to Ins (1,3,4,5) P4 | Cell signaling, motility | |
| KDR | Receptor protein-tyrosine kinase | Proliferation, survival, migration | |
| MAST3 | Serine/threonine kinase | Mitosis | |
| PAK3 | Serine/threonine p21-activating kinase | Cell cycle, migration | |
| PIK3R1 | Phosphorylation of the inositol ring of PI at the 3′ position | Cell signaling, vesicular trafficking, migration, insulin metabolism | |
| PIK3R5/P101-PI3K | Phosphorylation of the 3'OH of the inositol ring of phosphoinositide (PI) | Cell growth, proliferation, differentiation, motility, and intracellular trafficking | |
| PIP5KIA | Phosphorylation of 4-phosphate of PI | Endocytosis and cell migration | |
| PIP5K2B | Phosphorylation of 5′-phosphate of PI at the 4′OH | Cell signaling, proliferation, motility | |
| PKN3 | Serine/threonine-protein kinase | Cell growth, migration, adherence | |
| PRKCH | Serine/threonine-protein kinase | Cell signaling, proliferation, survival, motility | |
| PTK7 | Transduction of extracellular signals across the cell membrane | Wnt cell signaling, polarity, adhesion | |
| PRKACB/PKA C-β | cAMP-dependent catalytic subunit of serine/threonine-protein kinase | Regulation of lipid and glucose metabolism, cell signaling | |
| PCK1 | Catalyzes the formation of phosphoenolpyruvate from oxaloacetate | Regulation of gluconeogenesis | |
| STK11/LKB1 | Serine/threonine kinase, phosphorylates AMPK | Cell polarity and survival, metabolic reprogramming | |
| STK35/CLIK1 | Serine/threonine kinase | Cell cycle, migration | |
| STK38L/NDR1 | Mg++ binding serine/threonine kinase | Cytoskeletal reorganization, cell invasion | |
| STK4 | Serine/threonine kinase | apoptosis | |
| TYRO3 | Receptor protein-tyrosine kinase | Cell survival, proliferation and regulation |
Figure 1Differential fluorescent labeling of intracellular B. thailandensis upon siRNA knockdown of selected host kinase genes. (A) THP-1 cells pretreated with 50 nM siRNA for 72 h were infected with FITC-labeled Bt CDC2721121 for 2 h at MOI 10. Kanamycin (250 μg/ml) was then added for 3 h to suppress extracellular bacterial growth, after which the infected cells were cultured in antibiotic-free media for 20 h. Bacterial cells remaining extracellular were double-labeled with FITC and B. thailandensis rabbit antiserum/PE-conjugated anti-rabbit IgG, whereas intracellular bacteria were single-labeled with only FITC. Imaging flow cytometry analysis of infected THP-1 cells was performed using the Amnis ImageStreamX, and the frequencies of singly and double labeled bacteria were determined using the IDEAS 5.0 software. FITC, fluorescein isothiocyanate (ex495 nm/em519 nm); PE, Phycoerythrin (ex 488 nm/em575 nm). (B) The ratio of extracellular vs. intracellular bacteria in THP-1 cells siRNA-depleted of target kinases was used to evaluate kinase function in intracellular B. thailandensis proliferation. The average and standard deviation were determined from three independent experiments (Supplementary Table 2). The “*” denotes statistical significance (p < 0.05) for the ratio of extracellular to intracellular pathogen in cells siRNA-depleted of target gene compared to cells treated with control siRNA.
Figure 2PKC-η plays bigger role than PKC-α in unopsonized B. thailandensis intracellular survival and induction of host cell death. (A) Quantitative analysis of internalized Bt CDC2721121 was determined by plotting bacteria spot counts, 1–2 μm fluorescent puncti corresponding to bacteria size and fluorescent marker, against a normalized frequency, percentage of analyzed cells selected from the total number of single and focused cells. Bacterial counts in the cytoplasm that were singly labeled with FITC and not associated with the PE-labeled extracellular bacterial spots were calculated as described in the Materials and Methods. R, the gate excluding the cells exhibiting background fluorescence from the analysis, shows the mean value of fluorescence (MF) spots associated with intracellular bacteria per single host cell. R and NF (Normalized frequency) were determined by selective analysis of at least 5000 single and focused cells per sample using the IDEAS 5.0 software. A representative result of one out of 3 independent experiments is shown. (B) THP-1 cells were transfected with 50 nM siRNA against PRKCH or non-targeting control (CTL) siRNA and collected 72 h post treatment. Whole cell lysates were analyzed by Western blot using antibodies against PKC-η, PKC-α, and actin. (C) A549 cells transiently expressing PKC-η-DN, PKC-α-DN, and PKC-η-CAT, were infected with Bt CDC2721121 at MOI 50 for 1 h, treated with kanamycin (250 μg/ml) for 3 additional hours to suppress extracellular bacterial growth, after which the infected cells were cultured in antibiotic-free media. At 40 h post-infection, the percentage of dead A549 cells was calculated as a ratio of LDH activity in the conditioned media relative to total enzyme activity in the infected cells lysed with 0.1% Triton. The average and standard deviation from three independent experiments are shown. The “*” denotes statistical significance (p < 0.05) for % cell death in transfected samples compared to infected cells transfected with an empty vector (CTL) for each experimental condition.
Figure 3PKC-η is involved in host MARCKS phosphorylation upon bacterial infection (A) A549 cells were infected with Bt CDC2721121 at MOI 50 or Y. enterocolitica WA at MOI 20. After the indicated times, cells were lysed and levels of phosphorylated Ser152/156 in the MARCKS effector domain (pMARCKS) were quantified using the PathScan ELISA kit and compared to uninfected A549 cells. Cells were also treated with 100 nM PMA as a positive control. In all samples, pMARCKS levels were normalized to the total MARCKS protein levels. The average and standard deviation from three independent experiments are shown. (B) A549 cells were treated with 25 nM siRNA against MARCKS, PKC-η, or non-targeting control (CTL) for 72 h prior to infection with Bt CDC2721121. At the indicated time, cells were lysed and the levels of pMARCKS were quantified as fold change relative to uninfected A549 cells. The average and standard deviation from three independent experiments are shown. The “*” denotes statistical significance (p < 0.05) for fold pMARCKS change in samples treated with siRNA to MARCKS or PKC-η, compared to non-targeting siRNA samples (siR-CTL).
Figure 4Intracellular survival and spread of pathogenic Burkholderia is dependent on PKC-η and MARCKS function. (A) A549 cells were treated with 20 nM siRNA targeting MARCKS or PKC-η for 72 h prior to infection with Bt CDC2721121 at MOI 50. After 2 h of infection, cells were treated with 250 μg/ml kanamycin for 3 h, and incubated overnight in antibiotic-free media. Cells were collected 24 h post-infection and lysed with 0.1% Triton to release the intracellular bacteria. Colony forming units (CFU) were calculated from limiting dilutions of the cell lysates incubated on nutrient agar for 24 h at 37°C. LDH activity was measured in conditioned media and is presented as fold increase in the 24 vs. 2 h post infection. The average and standard deviation from three independent experiments are shown. The “*” denotes statistical significance (p < 0.05) for CFU counts and relative LDH activity in samples treated with siRNA to MARCKS or PKC-η, compared to control samples (siR-CTL). (B) A549 cells were treated with 20 nM siRNA against MARCKS or with non-targeting (siR-CTL) siRNA 72 h prior to infection with Bt CDC2721121 at MOI 50. Cells were fixed 18 h post-infection, stained with Giemsa, and the percentage of MNGC formation was calculated relative to normal cells per field of view. The average and standard deviations were derived from at least 10 fields of view covering an entire 20 mm culture dish. The “*” denotes statistical significance (p < 0.05) for % MNGC in samples treated with siRNA to MARCKS compared to samples treated with control siRNA (siR-CTL). The scale bar is 60 μM in length.
Figure 5Phagocytosis receptor usage determines the efficiency of intracellular Burkholderia proliferation. (A) A549 cells were (1) incubated with 3 mg/ml soluble mannan for 30 min and then infected with unopsonized Bt CDC2721121 at MOI 50, (2) not treated with mannan and infected with Bt CDC2721121 coated with anti-B.thailandensis rabbit serum (opson Bt), or (3) not treated with mannan and uninfected (CTL). pMARCKS levels in bacteria-infected cells were quantified and compared to uninfected cells. In parallel, A549 cells were collected after 2 h of infection for determination of intracellular bacterial counts. These cells were treated with 250 μg/ml kanamycin for 3 h to inhibit extracellular bacterial growth and incubated overnight in antibiotic-free media. At 24 h post-infection, a second set of samples were collected, and colony forming units (CFU) were calculated from limiting dilutions of the cell lysates incubated on nutrient agar for 24 h at 37°C. The replication index of intracellular Bt CDC2721121 was calculated as the CFU fold change at 24 vs. 2 h post-infection. The average and standard deviation from three independent experiments are shown. The “*” denotes statistical significance (p < 0.05) for fold change in pMARCKS and replication index in host cells treated with mannan or pathogen coated with serum, compared to CTL samples. (B) A549 and THP-1 cells were treated as described in (A), and LDH activity was measured in conditioned media 2 h post infection. After treatment with kanamycin (250 μg/ml) for 3 h, host cells were incubated for 24 h in antibiotic-free media and a second LDH measurement was taken. Relative LDH activity was determined as fold change between the 24 h and 2 h time points post-infection. The average and standard deviation from three independent experiments are shown. The “*” denotes statistical significance (p < 0.05) for relative LDH activity in experimental samples compared to untreated (CTL) samples. (C) A549 cells were treated with 25 nM siRNA targeting MRC1 or with non-targeting (CTL) siRNA and were infected with unopsonized Bt CDC2721121 at MOI 50. At 1 h and 24 h post-infection, cells were lysed with 0.1% Triton, and colony forming units (CFU) were calculated from limiting dilutions of the cell lysates incubated on nutrient agar for 24 h at 37°C. The ratio of CFU corresponding to intracellular bacteria from siR-MRC1 treated cells vs. cells treated with non-targeting siRNA is shown for each time point. The average mean and standard deviation from three independent experiments are shown. The “*” denotes statistical significance (p < 0.05) in number of CFUs between 1 and 24 h.
Figure 6Downregulation of PKC-η gene expression results in reduced cytoplasmic Burkholderia load and autophagy initiation. (A) A549 cells were infected with unopsonized or serum-coated Bt CDC2721121 (opson Bt) at MOI 50. Total RNA was isolated 5 h post infection, and transcript levels of ATG7 and MARCKS were quantified in infected vs. uninfected cells. The average and standard deviation from three independent experiments are shown. The “*” denotes statistical significance (p < 0.05) for RNA expression in infected host cells compared to uninfected samples. (B) A549 cells were treated with 20 nM siRNA targeting PKC-η or control siRNA (siR-CTL) for 72 h and then infected with unopsonized Bt CDC2721121 at MOI 50. Total RNA was isolated 18 h post infection and changes in gene expression profiles of PKC-η, MARCKS, and ATG7 were quantified relative to uninfected cells. The average and standard deviation from three independent experiments are shown. The “*” denotes statistical significance (p < 0.05) for RNA expression in samples treated with siR-PKC-η compared to their cognate samples treated with control siRNA. (C) A549 cells stably expressing RFP-LC3B were infected with unopsonized Bt CDC2721121 at MOI 50 for 6 h or treated with 0.5 μM rapamycin and analyzed by fluorescent microscopy to image LC3-positive autophagosomes. Scale bar, 10 μm. (D,E) Quantifying autophagosomes and cytoplasmic Bt CDC2721121 in lung epithelial cells with imaging flow cytometry. A549-RFP-LC3B cells were treated with 20 nM siRNA against PKC-η or non-targeting siRNA (siR-CTL) for 72 h prior to infection with FITC-labeled Bt CDC2721121 at MOI 50. No drug or 10 μM rapamycin was added 3 h before bacterial infection for controls. Cells were treated with 250 μg/ml kanamycin after 2 h of infection and collected 6 h post-infection for analysis. Cells were fixed with 3% paraformaldehyde (pH 6), washed, and then analyzed by Amnis ImageStreamX. The average number of RFP-LC3 spots was determined by the ratio of total RPF-positive puncta to the number of analyzed single cells. The average number of cytoplasmic bacteria per cell was determined by counting the FITC-positive spots in the green channel and not spots in the red channel divided by the total number of analyzed single cells. The average mean and standard deviation represent statistical analysis of 800 fluorescent positive cells per sample. The “*” denotes statistical significance (p < 0.05) for the number of cytoplasmic Burkholderia in cells depleted of PKC-η compared to untreated control cells (CTL).
Figure 7Coating of bacteria with opsonin determines receptor usage and the involvement of protein kinase C (PKC) isoforms in the regulation of phagocytosis-associated cell responses. Immunoglobulin G-opsonized bacteria triggers FcγRs-mediated phagocytosis engaging classical PKC isoform signaling pathways leading to pro-inflammatory cell responses, including the respiratory burst leading to efficient killing of bacteria within the lysosomes (Breton and Descoteaux, 2000; Dekker et al., 2000; Sudan et al., 2012). Interaction of bacterial glycoproteins with the host cell mannose receptor C-type 1, MRC1, stimulates signaling pathways regulated by the Ca2+-independent PKC isoforms resulting in escape of bacteria from the phagosome into the cytosol. Our hypothesis is that PKC inhibitors with selectivity to the novel, Ca2+-independent isoforms have the potential to act as host-directed antimicrobials blocking pathogen escape from phagosome destruction.